A cancer center working on new treatments and trials for various cancers.
Washington University/Siteman Cancer Center Lead Academic Site
This study is looking for patients with different types of cancer, including some rare ones, to join exciting new treatment trials that could help improve how we fight cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11252444 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer treatment through the Washington University/Siteman Cancer Center's participation in the National Clinical Trials Network (NCTN). The team aims to develop and conduct clinical trials for various cancers, including rare types and those driven by specific molecular characteristics. Patients may have the opportunity to participate in innovative therapeutic trials that could lead to improved cancer control and treatment outcomes. The research involves collaboration among experienced investigators who are dedicated to advancing cancer care.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with acute leukemia or other rare cancers who are seeking new treatment options.
Not a fit: Patients with common cancers that are already well-studied and have established treatment protocols may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and more effective treatments for patients with various types of cancer.
How similar studies have performed: Previous research within the NCTN framework has shown success in developing new cancer therapies, indicating that this approach is both tested and promising.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Bartlett, Nancy L — Washington University
- Study coordinator: Bartlett, Nancy L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.